O	O	0	10	Activation	Activation	B-NP	NN	O	0	ROOT	O
O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
O	O	14	17	the	the	B-NP	DT	O	8	NMOD	O
T10	B-Entity	18	20	NF	NF	I-NP	NN	B-protein	8	NMOD	B-protein
T10	I-Entity	20	21	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T10	I-Entity	21	27	kappaB	kappaB	I-NP	NN	I-protein	8	NMOD	I-protein
T11	I-Entity	28	41	transcription	transcription	I-NP	NN	I-protein	8	NMOD	I-protein
T11	I-Entity	42	48	factor	factor	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	49	51	in	in	B-PP	IN	O	1	NMOD	O
O	O	52	53	a	a	B-NP	DT	O	15	NMOD	O
O	O	54	55	T	T	I-NP	NN	B-cell_line	15	NMOD	B-cell_line
O	O	55	56	-	-	I-NP	HYPH	I-cell_line	15	P	I-cell_line
O	O	56	67	lymphocytic	lymphocytic	I-NP	JJ	I-cell_line	15	NMOD	I-cell_line
O	O	68	72	cell	cell	I-NP	NN	I-cell_line	15	NMOD	I-cell_line
O	O	73	77	line	line	I-NP	NN	I-cell_line	9	PMOD	I-cell_line
O	O	78	80	by	by	B-PP	IN	O	1	NMOD	O
O	O	81	93	hypochlorous	hypochlorous	B-NP	JJ	O	18	NMOD	O
O	O	94	98	acid	acid	I-NP	NN	O	16	PMOD	O
O	O	98	99	.	.	O	.	O	1	P	O

O	O	101	109	Reactive	Reactive	B-NP	JJ	O	3	NMOD	O
O	O	110	116	oxygen	oxygen	I-NP	NN	O	3	NMOD	O
O	O	117	124	species	specie	I-NP	NNS	O	11	SUB	O
O	O	125	126	(	(	O	(	O	6	DEP	O
O	O	126	129	ROS	ROS	B-NP	NNS	O	6	DEP	O
O	O	129	130	)	)	O	)	O	3	NMOD	O
O	O	131	135	such	such	B-PP	JJ	O	8	PMOD	O
O	O	136	138	as	as	I-PP	IN	O	3	NMOD	O
O	O	139	147	hydrogen	hydrogen	B-NP	NN	O	10	NMOD	O
O	O	148	156	peroxide	peroxide	I-NP	NN	O	8	PMOD	O
O	O	157	162	serve	serve	B-VP	VBP	O	0	ROOT	O
O	O	163	165	as	as	B-PP	IN	O	11	VMOD	O
O	O	166	172	second	second	B-NP	JJ	O	14	NMOD	O
O	O	173	183	messengers	messenger	I-NP	NNS	O	12	PMOD	O
O	O	184	186	in	in	B-PP	IN	O	11	VMOD	O
O	O	187	190	the	the	B-NP	DT	O	17	NMOD	O
O	O	191	200	induction	induction	I-NP	NN	O	15	PMOD	O
O	O	201	203	of	of	B-PP	IN	O	17	NMOD	O
O	O	204	207	the	the	B-NP	DT	O	21	NMOD	O
T12	B-Entity	208	221	transcription	transcription	I-NP	NN	B-protein	21	NMOD	B-protein
T12	I-Entity	222	228	factor	factor	I-NP	NN	I-protein	24	NMOD	I-protein
T12	I-Entity	229	231	NF	NF	I-NP	NN	B-protein	24	NMOD	B-protein
T12	I-Entity	231	232	-	-	B-NP	HYPH	I-protein	24	NMOD	I-protein
T12	I-Entity	232	238	kappaB	kappaB	I-NP	NN	I-protein	18	PMOD	I-protein
O	O	238	239	,	,	O	,	O	11	P	O
O	O	240	243	and	and	O	CC	O	25	PMOD	O
O	O	244	249	hence	hence	B-ADVP	RB	O	26	ROOT	O
O	O	250	252	in	in	B-PP	IN	O	27	PMOD	O
O	O	253	256	the	the	B-NP	DT	O	32	NMOD	O
O	O	257	267	activation	activation	I-NP	NN	O	32	NMOD	O
O	O	268	271	and	and	O	CC	O	32	NMOD	O
O	O	272	283	replication	replication	B-NP	NN	O	28	PMOD	O
O	O	284	286	of	of	B-PP	IN	O	32	NMOD	O
O	O	287	292	human	human	B-NP	JJ	O	37	NMOD	O
O	O	293	309	immunodeficiency	immunodeficiency	I-NP	NN	O	37	NMOD	O
O	O	310	315	virus	virus	I-NP	NN	O	37	NMOD	O
O	O	316	320	type	type	I-NP	NN	O	33	PMOD	O
O	O	321	322	1	1	I-NP	CD	O	37	NMOD	O
O	O	323	324	(	(	O	(	O	43	DEP	O
O	O	324	327	HIV	HIV	B-NP	NN	O	42	SUB	O
O	O	327	328	-	-	B-NP	HYPH	O	42	P	O
O	O	328	329	1	1	I-NP	CD	O	43	DEP	O
O	O	329	330	)	)	O	)	O	37	NMOD	O
O	O	331	333	in	in	B-PP	IN	O	32	NMOD	O
O	O	334	339	human	human	B-NP	JJ	B-cell_type	46	NMOD	B-cell_type
O	O	340	345	cells	cell	I-NP	NNS	I-cell_type	44	PMOD	I-cell_type
O	O	345	346	.	.	O	.	O	27	P	O

O	O	347	353	During	During	B-PP	IN	O	8	VMOD	O
O	O	354	366	inflammatory	inflammatory	B-NP	JJ	O	3	NMOD	O
O	O	367	376	reactions	reaction	I-NP	NNS	O	1	PMOD	O
O	O	376	377	,	,	O	,	O	8	P	O
O	O	378	382	many	many	B-NP	JJ	O	7	NMOD	O
O	O	383	392	oxidative	oxidative	I-NP	JJ	O	7	NMOD	O
O	O	393	400	species	specie	I-NP	NNS	O	8	SUB	O
O	O	401	404	are	be	B-VP	VBP	O	0	ROOT	O
O	O	405	413	produced	produce	I-VP	VBN	O	8	VC	O
O	O	413	414	,	,	O	,	O	8	P	O
O	O	415	418	one	one	B-NP	CD	O	12	NMOD	O
O	O	419	421	of	of	B-PP	IN	O	8	VMOD	O
O	O	422	427	which	which	B-NP	WDT	O	12	PMOD	O
O	O	428	430	is	be	B-VP	VBZ	O	12	SBAR	O
O	O	431	443	hypochlorous	hypochlorous	B-NP	JJ	O	16	NMOD	O
O	O	444	448	acid	acid	I-NP	NN	O	14	PRD	O
O	O	449	450	(	(	O	(	O	19	DEP	O
O	O	450	454	HOCl	HOCl	B-NP	NN	O	19	DEP	O
O	O	454	455	)	)	O	)	O	16	NMOD	O
O	O	455	456	,	,	O	,	O	16	P	O
O	O	457	462	which	which	B-NP	WDT	O	16	NMOD	O
O	O	463	465	is	be	B-VP	VBZ	O	21	SBAR	O
O	O	466	477	responsible	responsible	B-ADJP	JJ	O	22	PRD	O
O	O	478	481	for	for	B-PP	IN	O	23	AMOD	O
O	O	482	485	the	the	B-NP	DT	O	27	NMOD	O
O	O	486	498	microbicidal	microbicidal	I-NP	JJ	O	27	NMOD	O
O	O	499	506	effects	effect	I-NP	NNS	O	24	PMOD	O
O	O	507	509	of	of	B-PP	IN	O	27	NMOD	O
O	O	510	519	activated	activate	B-NP	VBN	O	32	NMOD	O
O	O	520	525	human	human	I-NP	JJ	B-cell_type	32	NMOD	B-cell_type
O	O	526	543	polymorphonuclear	polymorphonuclear	I-NP	JJ	I-cell_type	32	NMOD	I-cell_type
O	O	544	554	leukocytes	leukocyte	I-NP	NNS	I-cell_type	28	PMOD	I-cell_type
O	O	554	555	.	.	O	.	O	8	P	O

O	O	556	565	Treatment	Treatment	B-NP	NN	O	14	SUB	O
O	O	566	568	of	of	B-PP	IN	O	1	NMOD	O
O	O	569	570	a	a	B-NP	DT	O	8	NMOD	O
O	O	571	572	T	T	I-NP	NN	B-cell_line	8	NMOD	B-cell_line
O	O	572	573	-	-	I-NP	HYPH	I-cell_line	8	NMOD	I-cell_line
O	O	573	584	lymphocytic	lymphocytic	I-NP	JJ	I-cell_line	8	NMOD	I-cell_line
O	O	585	589	cell	cell	I-NP	NN	I-cell_line	8	NMOD	I-cell_line
O	O	590	594	line	line	I-NP	NN	I-cell_line	2	PMOD	I-cell_line
O	O	595	599	with	with	B-PP	IN	O	1	NMOD	O
O	O	600	610	micromolar	micromolar	B-NP	JJ	O	11	NMOD	O
O	O	611	625	concentrations	concentration	I-NP	NNS	O	9	PMOD	O
O	O	626	628	of	of	B-PP	IN	O	11	NMOD	O
O	O	629	633	HOCl	HOCl	B-NP	NN	O	12	PMOD	O
O	O	634	642	promoted	promote	B-VP	VBD	O	0	ROOT	O
O	O	643	646	the	the	B-NP	DT	O	16	NMOD	O
O	O	647	657	appearance	appearance	I-NP	NN	O	14	OBJ	O
O	O	658	660	of	of	B-PP	IN	O	16	NMOD	O
T13	B-Entity	661	674	transcription	transcription	B-NP	NN	B-protein	19	NMOD	B-protein
T13	I-Entity	675	681	factor	factor	I-NP	NN	I-protein	22	NMOD	I-protein
T13	I-Entity	682	684	NF	NF	I-NP	NN	B-protein	22	NMOD	B-protein
T13	I-Entity	684	685	-	-	B-NP	HYPH	I-protein	22	NMOD	I-protein
T13	I-Entity	685	691	kappaB	kappaB	I-NP	NN	I-protein	17	PMOD	I-protein
O	O	692	693	(	(	O	(	O	29	DEP	O
O	O	693	696	the	the	B-NP	DT	O	28	NMOD	O
T14	B-Entity	697	708	heterodimer	heterodimer	I-NP	NN	B-protein	28	NMOD	B-protein
T1,T14	B-Protein,I-Entity	709	712	p50	p50	I-NP	NN	I-protein	28	NMOD	I-protein
T14	I-Entity	712	713	/	/	B-NP	SYM	O	28	P	O
T2,T14	B-Protein,I-Entity	713	716	p65	p65	I-NP	NN	B-protein	29	DEP	B-protein
O	O	716	717	)	)	O	)	O	22	NMOD	O
O	O	718	720	in	in	B-PP	IN	O	16	NMOD	O
O	O	721	724	the	the	B-NP	DT	O	32	NMOD	O
O	O	725	732	nucleus	nucleus	I-NP	NN	O	30	PMOD	O
O	O	733	735	of	of	B-PP	IN	O	32	NMOD	O
O	O	736	739	the	the	B-NP	DT	O	35	NMOD	O
O	O	740	745	cells	cell	I-NP	NNS	O	33	PMOD	O
O	O	745	746	,	,	O	,	O	14	P	O
O	O	747	751	even	even	B-ADVP	RB	O	38	PMOD	O
O	O	752	754	in	in	B-PP	IN	O	14	VMOD	O
O	O	755	758	the	the	B-NP	DT	O	40	NMOD	O
O	O	759	766	absence	absence	I-NP	NN	O	38	PMOD	O
O	O	767	769	of	of	B-PP	IN	O	40	NMOD	O
O	O	770	772	de	de	B-NP	FW	O	43	AMOD	O
O	O	773	777	novo	novo	I-NP	FW	O	45	NMOD	O
O	O	778	785	protein	protein	I-NP	NN	O	45	NMOD	O
O	O	786	795	synthesis	synthesis	I-NP	NN	O	41	PMOD	O
O	O	795	796	.	.	O	.	O	14	P	O

O	O	797	804	Western	Western	B-NP	NN	O	3	NMOD	O
O	O	805	809	blot	blot	I-NP	NN	O	3	NMOD	O
O	O	810	818	analysis	analysis	I-NP	NN	O	14	SUB	O
O	O	819	821	of	of	B-PP	IN	O	3	NMOD	O
O	O	822	825	the	the	B-NP	DT	O	10	NMOD	O
T15	B-Entity	826	828	NF	NF	I-NP	NN	B-protein	10	NMOD	B-protein
T15	I-Entity	828	829	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T15	I-Entity	829	835	kappaB	kappaB	I-NP	NN	I-protein	10	NMOD	I-protein
O	O	836	846	inhibitory	inhibitory	I-NP	JJ	I-protein	10	NMOD	I-protein
O	O	847	855	subunits	subunit	I-NP	NNS	I-protein	4	PMOD	I-protein
O	O	856	857	(	(	O	(	O	13	DEP	O
O	O	857	864	IkappaB	IkappaB	B-NP	NN	B-protein	13	DEP	B-protein
O	O	864	865	)	)	O	)	O	10	NMOD	O
O	O	866	878	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	O
O	O	879	883	that	that	B-SBAR	IN	O	14	VMOD	O
O	O	884	888	both	both	O	CC	O	23	NMOD	O
T3	B-Protein	889	896	IkappaB	IkappaB	B-NP	NN	B-protein	20	NMOD	B-protein
T3	I-Protein	896	897	-	-	I-NP	HYPH	O	20	NMOD	O
T3	I-Protein	897	902	alpha	alpha	I-NP	SYM	O	20	NMOD	O
O	O	903	914	proteolysis	proteolysis	I-NP	NN	O	23	NMOD	O
O	O	915	918	and	and	I-NP	CC	O	23	NMOD	O
T4	B-Protein	919	923	p105	p105	I-NP	NN	B-protein	23	NMOD	B-protein
O	O	924	934	processing	processing	I-NP	NN	O	24	SUB	O
O	O	935	939	were	be	B-VP	VBD	O	15	SBAR	O
O	O	940	947	induced	induce	I-VP	VBN	O	24	VC	O
O	O	948	950	by	by	B-PP	IN	O	25	VMOD	O
O	O	951	954	the	the	B-NP	DT	O	28	NMOD	O
O	O	955	964	treatment	treatment	I-NP	NN	O	26	PMOD	O
O	O	964	965	.	.	O	.	O	14	P	O

T16	B-Entity	966	968	NF	NF	B-NP	NN	B-protein	3	NMOD	B-protein
T16	I-Entity	968	969	-	-	I-NP	HYPH	I-protein	3	NMOD	I-protein
T16	I-Entity	969	975	kappaB	kappaB	I-NP	NN	I-protein	4	NMOD	I-protein
O	O	976	986	activation	activation	I-NP	NN	O	5	SUB	O
O	O	987	990	was	be	B-VP	VBD	O	0	ROOT	O
O	O	991	995	very	very	B-ADJP	RB	O	7	AMOD	O
O	O	996	1005	effective	effective	I-ADJP	JJ	O	5	PRD	O
O	O	1006	1010	when	when	B-ADVP	WRB	O	5	VMOD	O
O	O	1011	1016	cells	cell	B-NP	NNS	O	10	SUB	O
O	O	1017	1021	were	be	B-VP	VBD	O	8	SBAR	O
O	O	1022	1031	subjected	subject	I-VP	VBN	O	10	VC	O
O	O	1032	1034	to	to	B-PP	TO	O	11	VMOD	O
O	O	1035	1047	hyperthermia	hyperthermia	B-NP	NN	O	12	PMOD	O
O	O	1048	1054	before	before	B-PP	IN	O	11	VMOD	O
O	O	1055	1060	being	be	B-VP	VBG	O	14	PMOD	O
O	O	1061	1068	treated	treat	I-VP	VBN	O	15	VC	O
O	O	1069	1073	with	with	B-PP	IN	O	16	VMOD	O
O	O	1074	1078	HOCl	HOCl	B-NP	NN	O	17	PMOD	O
O	O	1078	1079	.	.	O	.	O	5	P	O

O	O	1080	1087	Various	Various	B-NP	JJ	O	2	NMOD	O
O	O	1088	1100	antioxidants	antioxidant	I-NP	NNS	O	16	NMOD	O
O	O	1100	1101	,	,	O	,	O	2	P	O
O	O	1102	1106	such	such	B-PP	JJ	O	5	PMOD	O
O	O	1107	1109	as	as	I-PP	IN	O	2	NMOD	O
O	O	1110	1121	pyrrolidine	pyrrolidine	B-NP	NN	O	7	NMOD	O
O	O	1122	1137	dithiocarbamate	dithiocarbamate	I-NP	NN	O	5	PMOD	O
O	O	1137	1138	,	,	O	,	O	16	P	O
O	O	1139	1140	p	p	B-NP	NN	O	16	NMOD	O
O	O	1140	1141	-	-	B-NP	HYPH	O	16	NMOD	O
O	O	1141	1154	bromophenacyl	bromophenacyl	I-NP	NN	O	16	NMOD	O
O	O	1154	1155	-	-	B-NP	HYPH	O	16	NMOD	O
O	O	1155	1162	bromide	bromide	I-NP	NN	O	16	NMOD	O
O	O	1163	1166	and	and	O	CC	O	16	NMOD	O
O	O	1167	1187	nordihydroguaiaretic	nordihydroguaiaretic	B-NP	JJ	O	16	NMOD	O
O	O	1188	1192	acid	acid	I-NP	NN	O	17	SUB	O
O	O	1193	1198	could	could	B-VP	MD	O	0	ROOT	O
O	O	1199	1207	strongly	strongly	I-VP	RB	O	17	VMOD	O
O	O	1208	1214	reduce	reduce	I-VP	VB	O	17	VC	O
T17	B-Entity	1215	1217	NF	NF	B-NP	NN	B-protein	22	NMOD	B-protein
T17	I-Entity	1217	1218	-	-	I-NP	HYPH	I-protein	22	NMOD	I-protein
T17	I-Entity	1218	1224	kappaB	kappaB	I-NP	NN	I-protein	23	NMOD	I-protein
O	O	1225	1238	translocation	translocation	I-NP	NN	O	19	OBJ	O
O	O	1238	1239	,	,	O	,	O	17	P	O
O	O	1240	1253	demonstrating	demonstrate	B-VP	VBG	O	17	VMOD	O
O	O	1254	1257	the	the	B-NP	DT	O	27	NMOD	O
O	O	1258	1268	importance	importance	I-NP	NN	O	25	OBJ	O
O	O	1269	1271	of	of	B-PP	IN	O	27	NMOD	O
O	O	1272	1281	oxidative	oxidative	B-NP	JJ	O	30	NMOD	O
O	O	1282	1289	species	specie	I-NP	NNS	O	28	PMOD	O
O	O	1290	1292	in	in	B-PP	IN	O	27	NMOD	O
O	O	1293	1296	the	the	B-NP	DT	O	34	NMOD	O
O	O	1297	1309	transduction	transduction	I-NP	NN	O	34	NMOD	O
O	O	1310	1319	mechanism	mechanism	I-NP	NN	O	31	PMOD	O
O	O	1319	1320	.	.	O	.	O	17	P	O

O	O	1321	1329	Moreover	Moreover	B-ADVP	RB	O	12	VMOD	O
O	O	1329	1330	,	,	O	,	O	12	P	O
O	O	1331	1334	ACH	ACH	B-NP	NN	B-cell_line	6	NMOD	B-cell_line
O	O	1334	1335	-	-	O	HYPH	I-cell_line	6	NMOD	I-cell_line
O	O	1335	1336	2	2	B-NP	CD	I-cell_line	6	NMOD	I-cell_line
O	O	1337	1342	cells	cell	I-NP	NNS	I-cell_line	12	SUB	I-cell_line
O	O	1343	1350	treated	treat	B-VP	VBN	O	6	NMOD	O
O	O	1351	1355	with	with	B-PP	IN	O	7	VMOD	O
O	O	1356	1360	HOCl	HOCl	B-NP	NN	O	11	NMOD	O
O	O	1361	1363	or	or	I-NP	CC	O	11	NMOD	O
O	O	1364	1368	H2O2	H2O2	I-NP	NN	O	8	PMOD	O
O	O	1369	1377	released	release	B-VP	VBD	O	0	ROOT	O
T5	B-Protein	1378	1384	tumour	tumour	B-NP	NN	B-protein	15	NMOD	B-protein
T5	I-Protein	1385	1393	necrosis	necrosis	I-NP	NN	I-protein	15	NMOD	I-protein
T5	I-Protein	1394	1400	factor	factor	I-NP	NN	I-protein	17	NMOD	I-protein
T5	I-Protein	1400	1401	-	-	O	HYPH	O	17	P	O
T5	I-Protein	1401	1406	alpha	alpha	B-NP	SYM	O	12	OBJ	O
O	O	1407	1408	(	(	O	(	O	22	DEP	O
T6	B-Protein	1408	1411	TNF	TNF	B-NP	NN	B-protein	21	NMOD	B-protein
T6	I-Protein	1411	1412	-	-	B-NP	HYPH	I-protein	21	NMOD	I-protein
T6	I-Protein	1412	1417	alpha	alpha	I-NP	NN	I-protein	22	DEP	I-protein
O	O	1417	1418	)	)	O	)	O	17	NMOD	O
O	O	1419	1421	in	in	B-PP	IN	O	12	VMOD	O
O	O	1422	1425	the	the	B-NP	DT	O	25	NMOD	O
O	O	1426	1438	supernatants	supernatant	I-NP	NNS	O	23	PMOD	O
O	O	1438	1439	.	.	O	.	O	12	P	O

O	O	1440	1443	The	The	B-NP	DT	O	2	NMOD	O
O	O	1444	1454	importance	importance	I-NP	NN	O	17	SUB	O
O	O	1455	1457	of	of	B-PP	IN	O	2	NMOD	O
T7	B-Protein	1458	1461	TNF	TNF	B-NP	NN	B-protein	7	NMOD	B-protein
T7	I-Protein	1461	1462	-	-	O	HYPH	O	7	NMOD	O
T7	I-Protein	1462	1467	alpha	alpha	O	SYM	O	7	NMOD	O
O	O	1468	1475	release	release	B-NP	NN	O	3	PMOD	O
O	O	1476	1478	in	in	B-PP	IN	O	7	NMOD	O
T18	B-Entity	1479	1481	NF	NF	B-NP	NN	B-protein	11	NMOD	B-protein
T18	I-Entity	1481	1482	-	-	B-NP	HYPH	I-protein	11	NMOD	I-protein
T18	I-Entity	1482	1488	kappaB	kappaB	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	1489	1498	induction	induction	I-NP	NN	O	8	PMOD	O
O	O	1499	1501	by	by	B-PP	IN	O	12	NMOD	O
O	O	1502	1506	HOCl	HOCl	B-NP	NN	O	16	NMOD	O
O	O	1507	1509	or	or	I-NP	CC	O	16	NMOD	O
O	O	1510	1514	H2O2	H2O2	I-NP	NN	O	13	PMOD	O
O	O	1515	1518	was	be	B-VP	VBD	O	51	VMOD	O
O	O	1519	1531	demonstrated	demonstrate	I-VP	VBN	O	17	VC	O
O	O	1532	1534	by	by	B-PP	IN	O	18	VMOD	O
O	O	1535	1538	the	the	B-NP	DT	O	21	NMOD	O
O	O	1539	1543	fact	fact	I-NP	NN	O	19	PMOD	O
O	O	1544	1548	that	that	B-SBAR	IN	O	21	NMOD	O
O	O	1548	1549	:	:	O	:	O	34	P	O
O	O	1550	1551	(	(	B-LST	(	O	25	DEP	O
O	O	1551	1552	1	1	I-LST	LS	O	34	VMOD	O
O	O	1552	1553	)	)	O	)	O	25	DEP	O
O	O	1554	1557	the	the	B-NP	DT	O	29	NMOD	O
O	O	1558	1565	nuclear	nuclear	I-NP	JJ	O	29	NMOD	O
O	O	1566	1576	appearance	appearance	I-NP	NN	O	34	SUB	O
O	O	1577	1579	of	of	B-PP	IN	O	29	NMOD	O
T19	B-Entity	1580	1582	NF	NF	B-NP	NN	B-protein	33	NMOD	B-protein
T19	I-Entity	1582	1583	-	-	B-NP	HYPH	I-protein	33	NMOD	I-protein
T19	I-Entity	1583	1589	kappaB	kappaB	I-NP	NN	I-protein	30	PMOD	I-protein
O	O	1590	1593	was	be	B-VP	VBD	O	22	SBAR	O
O	O	1594	1602	promoted	promote	I-VP	VBN	O	34	VC	O
O	O	1603	1605	in	in	B-PP	IN	O	35	VMOD	O
O	O	1606	1615	untreated	untreated	B-NP	JJ	B-cell_type	38	NMOD	B-cell_type
O	O	1616	1621	cells	cell	I-NP	NNS	I-cell_type	36	PMOD	I-cell_type
O	O	1621	1622	;	;	O	:	O	17	P	O
O	O	1623	1626	and	and	O	CC	O	17	VMOD	O
O	O	1627	1628	(	(	B-LST	(	O	42	DEP	O
O	O	1628	1629	2	2	I-LST	LS	O	51	VMOD	O
O	O	1629	1630	)	)	O	)	O	42	DEP	O
O	O	1631	1640	synergism	synergism	B-NP	NN	O	51	SUB	O
O	O	1641	1648	between	between	B-PP	IN	O	44	NMOD	O
T8	B-Protein	1649	1652	TNF	TNF	B-NP	NN	B-protein	48	NMOD	B-protein
T8	I-Protein	1652	1653	-	-	O	HYPH	O	48	P	O
T8	I-Protein	1653	1658	alpha	alpha	B-NP	SYM	O	50	NMOD	O
O	O	1659	1662	and	and	O	CC	O	50	NMOD	O
O	O	1663	1667	HOCl	HOCl	B-NP	NN	O	45	PMOD	O
O	O	1668	1671	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1672	1680	detected	detect	I-VP	VBN	O	51	VC	O
O	O	1680	1681	.	.	O	.	O	51	P	O

O	O	1682	1694	Collectively	Collectively	B-ADVP	RB	O	5	VMOD	O
O	O	1694	1695	,	,	O	,	O	5	P	O
O	O	1696	1701	these	these	B-NP	DT	O	4	NMOD	O
O	O	1702	1709	results	result	I-NP	NNS	O	5	SUB	O
O	O	1710	1717	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1718	1722	that	that	B-SBAR	IN	O	5	VMOD	O
O	O	1723	1727	HOCl	HOCl	B-NP	NN	O	8	SUB	O
O	O	1728	1734	should	should	B-VP	MD	O	6	SBAR	O
O	O	1735	1737	be	be	I-VP	VB	O	8	VC	O
O	O	1738	1748	considered	consider	I-VP	VBN	O	9	VC	O
O	O	1749	1751	as	as	B-PP	IN	O	10	VMOD	O
O	O	1752	1754	an	an	B-NP	DT	O	14	NMOD	O
O	O	1755	1764	oxidative	oxidative	I-NP	JJ	O	14	NMOD	O
O	O	1765	1772	species	specie	I-NP	NNS	O	11	PMOD	O
O	O	1773	1780	capable	capable	B-ADJP	JJ	O	14	NMOD	O
O	O	1781	1783	of	of	B-PP	IN	O	15	AMOD	O
O	O	1784	1792	inducing	induce	B-VP	VBG	O	16	PMOD	O
T20	B-Entity	1793	1795	NF	NF	B-NP	NN	B-protein	20	NMOD	B-protein
T20	I-Entity	1795	1796	-	-	B-NP	HYPH	I-protein	20	NMOD	I-protein
T20	I-Entity	1796	1802	kappaB	kappaB	I-NP	NN	I-protein	17	OBJ	I-protein
O	O	1803	1805	in	in	B-PP	IN	O	17	VMOD	O
O	O	1806	1807	a	a	B-NP	DT	O	27	NMOD	O
O	O	1808	1809	T	T	I-NP	NN	B-cell_line	27	NMOD	B-cell_line
O	O	1809	1810	-	-	I-NP	HYPH	I-cell_line	27	P	I-cell_line
O	O	1810	1821	lymphocytic	lymphocytic	I-NP	JJ	I-cell_line	27	NMOD	I-cell_line
O	O	1822	1826	cell	cell	I-NP	NN	I-cell_line	27	NMOD	I-cell_line
O	O	1827	1831	line	line	I-NP	NN	I-cell_line	21	PMOD	I-cell_line
O	O	1832	1839	through	through	B-PP	IN	O	17	VMOD	O
O	O	1840	1841	a	a	B-NP	DT	O	31	NMOD	O
O	O	1842	1854	transduction	transduction	I-NP	NN	O	31	NMOD	O
O	O	1855	1864	mechanism	mechanism	I-NP	NN	O	28	PMOD	O
O	O	1865	1874	involving	involve	B-VP	VBG	O	31	NMOD	O
O	O	1875	1878	ROS	ROS	B-NP	NNS	O	32	OBJ	O
O	O	1878	1879	,	,	O	,	O	17	P	O
O	O	1880	1883	and	and	O	CC	O	17	VMOD	O
O	O	1884	1890	having	have	B-VP	VBG	O	17	VMOD	O
O	O	1891	1892	a	a	B-NP	DT	O	41	NMOD	O
O	O	1893	1897	long	long	I-NP	JJ	O	41	NMOD	O
O	O	1897	1898	-	-	I-NP	HYPH	O	41	NMOD	O
O	O	1898	1906	distance	distance	I-NP	NN	O	41	NMOD	O
O	O	1907	1913	effect	effect	I-NP	NN	O	36	OBJ	O
O	O	1914	1921	through	through	B-PP	IN	O	36	VMOD	O
O	O	1922	1932	subsequent	subsequent	B-NP	JJ	O	47	NMOD	O
T9	B-Protein	1933	1936	TNF	TNF	I-NP	NN	B-protein	47	NMOD	B-protein
T9	I-Protein	1936	1937	-	-	O	HYPH	O	47	NMOD	O
T9	I-Protein	1937	1942	alpha	alpha	B-NP	SYM	O	47	NMOD	O
O	O	1943	1950	release	release	I-NP	NN	O	42	PMOD	O
O	O	1950	1951	.	.	O	.	O	5	P	O
